Domov › Srčno popuščanje › Ohio › Cincinnati
Klinične študije za Srčno popuščanje v Cincinnati, OH
24 študij za Srčno popuščanje išče udeležence na lokacijah v Cincinnati in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Vključevanje udeležencevFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
BiVACOR® Total Artificial Heart Early Feasibility Study
Vključevanje udeležencev
- The Christ Hospital, Cincinnati
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Vključevanje udeležencevFaza 3
- The Lindner Research Center at the Christ Hospital, Cincinnati
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Vključevanje udeležencev
- The Christ Hospital, Cincinnati
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Vključevanje udeležencevFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Vključevanje udeležencevFaza 3
- Cincinnati, OH Investigative Site 10088, Cincinnati
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
Vključevanje udeležencev
- The Christ Hospital - Cincinnati, Cincinnati
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Vključevanje udeležencevFaza 2
- Local Institution - 129, Cincinnati
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
Vključevanje udeležencevFaza 2/3
- Cincinnati Children's Hospital Medical Center ( Site 0034), Cincinnati
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
Vključevanje udeležencevFaza 2
- The Lindner Center for Research & Education at The Christ Hospital, Cincinnati
NORM-HF Pivotal Study
Vključevanje udeležencev
- Christ Hospital Lindner, Cincinnati
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Cincinnati Childrens Hospital Medical Center, Cincinnati
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Vključevanje udeležencevOpazovalna študija
- Cincinnati, Cincinnati
- Edgewood, Edgewood · 8 mi stran
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Vključevanje udeležencevOpazovalna študija
- Christ Hospital Health Network, Cincinnati
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Vključevanje udeležencevFaza 3
- Lindner Center,Christ Hospital, Cincinnati
Alleviant ALLAY-HF Study
Vključevanje udeležencev
- St. Elizabeth Healthcare, Edgewood · 8 mi stran
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Vključevanje udeležencevFaza 3
- FIN- 10112, Cincinnati, OH, Cincinnati
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Vključevanje udeležencev
- The Christ Hospital- Cincinnati, Cincinnati
- University of Cincinnati, Cincinnati
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Vključevanje udeležencevFaza 3
- Cincinnati Children's Hospital Medical Center | Division of Nephrology and Hypertension, Cincinnati
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Vključevanje udeležencev
- Christ Hospital, Cincinnati
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Vključevanje udeležencev
- Lindner Research Center at the Christ Hospital, Cincinnati
Left vs Left Randomized Clinical Trial
Vključevanje udeležencev
- The Christ Hospital, Cincinnati
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
Vključevanje udeležencevOpazovalna študija
- The Lindner Research Center at The Christ Hospital, Cincinnati
- St. Elizabeth Healthcare, Edgewood · 8 mi stran
Študije za Srčno popuščanje v drugih mestih
- New York City, NY51 študij
- Boston, MA44 študij
- Dallas, TX42 študij
- Houston, TX36 študij
- Cleveland, OH33 študij
- Chicago, IL31 študij
- Philadelphia, PA31 študij
- San Francisco, CA29 študij
- St. Louis, MO26 študij
- Durham, NC26 študij
- Kansas City, MO25 študij
- Atlanta, GA25 študij
Druge študije v Cincinnati
- Nemalicelični pljučni rak35 študij
- Rak (vse vrste)27 študij
- Rak dojke25 študij
- Kolorektalni rak21 študij
- Akutna mieločna levkemija20 študij
- Metastatski rak20 študij
- Rak jajčnikov19 študij
- Rak pljuč19 študij
- Debelost19 študij
- Rak prostate18 študij
- Množni mielom17 študij
- Melanom17 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.